Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 2;14:4085–4099. doi: 10.2147/DDDT.S270185

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Cheng et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

TPH-2, MAO-A, and 5-HT3 receptor immunostaining in medulla oblongata.

Notes: Values were expressed as mean ± SEM (n = 6). **P < 0.01, compared to the control group; ^#P < 0.05, ^##P < 0.01, compared to the cisplatin model group. (magnification × 200, scale bars = 100 μm).

Abbreviations: Con, normal control group; G-con, the [6]-gingerol control group; O-con, the ondansetron control group; Model, the cisplatin model group; O-treated, the ondansetron-treated model group; GH-treated, the high dosage of [6]-gingerol-treated model group; GL-treated, the low dosage of [6]-gingerol-treated model group.